Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CDXC - Chromadex Corp


IEX Last Trade
3.47
0.110   3.170%

Share volume: 199,674
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$3.36
0.11
3.27%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
29%
Profitability 25%
Dept financing 13%
Liquidity 75%
Performance 25%
Company vs Stock growth
vs
Performance
5 Days
-1.71%
1 Month
15.38%
3 Months
21.91%
6 Months
100.58%
1 Year
118.35%
2 Year
146.43%
Key data
Stock price
$3.47
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$1.25 - $4.65
52 WEEK CHANGE
$1.21
MARKET CAP 
261.969 M
YIELD 
N/A
SHARES OUTSTANDING 
75.933 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
0.55
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$296,662
AVERAGE 30 VOLUME 
$272,750
Company detail
CEO: Robert Fried
Region: US
Website: https://chromadex.com/default.aspx
Employees: 125
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

chromadex corp. is an integrated, global nutraceutical company devoted to improving the way people age. chromadex scientists partner with leading universities and research institutions worldwide to uncover the full potential of nad and identify and develop novel, science-based ingredients including pteropure® pterostilbene; purenergy®, a caffeine-pteropure® co-crystal; anthorigin™, anthocyanins and niagen® nicotinamide riboside - sold directly to consumers as the supplement, tru niagen®. tru niagen® is helping the world age better®. for more, visit www.chromadex.com like us on facebook here: https://www.facebook.com/chromadex or follow us on twitter @chromadex chromadex® is publicly-traded company (nasdaq:cdxc).

Recent news